RONALD A. SEFF, M.D. - Corporate Board Profile

UNIVERSAL SECURITY INSTRUMENTS INC

Filing Date	Source Excerpt
2003-07-24	Mr. Luskin, Dr. Silverman, and Dr. Seff each received an option to purchase 5,000 Shares ... Each of these directors also received an option ... Furthermore, during the Company's fiscal year ended March 31, 2003, the Company paid to each of Mr. Luskin, Dr. Silverman, and Dr. Seff a $10,000 fee for annual service as a director.
2004-07-29	During the Company's fiscal year ended March 31, 2004, the Company paid to each of Mr. Luskin, Dr. Silverman, and Dr. Seff a $10,000 fee for annual service as a director, payable in cash or Shares (computed at the closing price as reported by the Amex on the date of the payment). The members of the Audit Committee are Mr. Luskin (Chairman), Dr. Seff and Dr. Silverman. The Compensation Committee membership consists of Mr. Luskin (Chairman), Dr. Seff and Dr. Silverman.
2005-07-29	The members of the Audit Committee are Mr. Luskin (Chairman), Dr. Seff and Dr. Silverman, none of whom is an employee of the Company and each of whom is independent under existing Amex and Securities and Exchange Commission (SEC) requirements. During the Company's fiscal year ended March 31, 2005, the Company paid to each of Mr. Luskin, Dr. Silverman, and Dr. Seff a $10,000 fee for annual service as a director, payable in cash or Shares (computed at the closing price as reported by the Amex on the date of the payment).
2006-07-26	The members of the Audit Committee are Mr. Luskin (Chairman), Dr. Seff and Dr. Silverman, none of whom is an employee of the Company and each of whom is independent under existing Amex and Securities and Exchange Commission (SEC) requirements. During the Company's fiscal year ended March 31, 2006, the Company paid to each of Mr. Luskin, Dr. Silverman, and Dr. Seff a $10,000 fee for annual service as a director.
2007-07-30	Ronald A. Seff, M.D. has been in the private practice of ophthalmology since 1977. The members of the Audit Committee are Mr. Luskin (Chairman), Dr. Seff and Dr. Silverman. The Board’s Compensation Committee consists of Mr. Luskin (Chairman), Dr. Seff and Dr. Silverman. During the Company’s fiscal year ended March 31, 2007, the Company paid to Dr. Seff a $10,000 fee for annual service as a director.
2008-07-29	The members of the Audit Committee during the fiscal year ended March 31, 2008 were Mr. Luskin (Chairman), Dr. Seff and Dr. Silverman. Effective July 24, 2008, Mr. Bormel has been appointed to the Audit Committee to replace Dr. Silverman and has also been designated to chair the Audit Committee. None of the Audit Committee members is an employee of the Company and each is independent under existing Amex and Securities and Exchange Commission (SEC) requirements. The Board’s Compensation Committee consists of Mr. Luskin (Chairman), Dr. Seff and Mr. Bormel, none of whom is an employee of the Company and each of whom is independent under existing Amex and SEC requirements. During the Company’s fiscal year ended March 31, 2008, the Company paid to Dr. Seff a $10,000 fee for annual service as a director.
2009-07-21	The members of the Audit Committee during the fiscal year ended March 31, 2009 were Mr. Bormel (Chairman), Dr. Seff and Mr. Luskin. None of the Audit Committee members is an employee of the Company and each is independent under existing NYSE Amex and SEC requirements. The Board has examined the SEC’s definition of “audit committee financial expert” and determined that Mr. Bormel satisfies this definition. Accordingly, Mr. Bormel has been designated by the Board as the Company’s audit committee financial expert. During the fiscal year ended March 31, 2009, the Audit Committee met four times. The Board has adopted a written charter for the Audit Committee, which is attached to this Proxy Statement as Appendix A. The Board’s Compensation Committee consists of Mr. Luskin (Chairman), Dr. Seff and Mr. Bormel, none of whom is an employee of the Company and each of whom is independent under existing NYSE Amex and SEC requirements. The Compensation Committee is charged with reviewing and determining the compensation of the Chief Executive Officer and the other executive officers of the Company. The Board has not adopted a charter with respect to the Compensation Committee. The Compensation Committee met one time during the fiscal year ended March 31, 2009. For the Company’s fiscal year ended March 31, 2009, each outside director was entitled to a $10,000 annual fee for annual service as a director. The following table summarizes the compensation paid to directors for the fiscal year ended March 31, 2009: Ronald A. Seff, M.D. $10,000 total.
2010-07-28	Ronald A. Seff, M.D. has been in the private practice of ophthalmology since 1977. ... Dr. Seff has served on the Audit and Compensation Committees of the Company for eight years. ... The members of the Audit Committee during the fiscal year ended March 31, 2010 were Mr. Bormel (Chairman), Dr. Seff and Mr. Luskin. ... The Compensation Committee consists of Mr. Luskin (Chairman), Dr. Seff and Mr. Bormel. ... For the Company’s fiscal year ended March 31, 2010, each outside director was entitled to a $10,000 annual fee for annual service as a director. ... The following table summarizes the compensation paid to directors for the fiscal year ended March 31, 2010: Ronald A. Seff, M.D. $10,000 total.
2011-07-26	The members of the Audit Committee during the fiscal year ended March 31, 2011 were Mr. Bormel (Chairman), Dr. Seff and Mr. Luskin... The Compensation Committee consists of Mr. Luskin (Chairman), Dr. Seff and Mr. Bormel... For the Company’s fiscal year ended March 31, 2011, each outside director was entitled to a $10,000 annual fee... Ronald A. Seff, M.D. $10,000 total compensation.
2012-07-24	The members of the Audit Committee during the fiscal year ended March 31, 2012 were Mr. Bormel (Chairman), Dr. Seff and Mr. Luskin. ... The Board’s Compensation Committee consists of Mr. Luskin (Chairman), Dr. Seff and Mr. Bormel, none of whom is an employee of the Company and each of whom is independent under existing NYSE Amex and SEC requirements. ... During the Company’s fiscal year ended March 31, 2012, Mr. Grossblatt, the Company’s president and chief executive officer, received no additional compensation for serving as a director. For the Company’s fiscal year ended March 31, 2012, each outside director was entitled to a $10,000 annual fee for annual service as a director. Directors’ compensation is payable in cash or Shares (computed at the closing price as reported by the NYSE Amex on the date of the payment). The following table summarizes the compensation paid to directors for the fiscal year ended March 31, 2012: ... Ronald A. Seff, M.D., $18,786 total compensation.
2013-07-24	The members of the Audit Committee during the fiscal year ended March 31, 2013 were Mr. Bormel (Chairman), Dr. Seff and Mr. Luskin. ... The Board's Compensation Committee consists of Mr. Luskin (Chairman), Dr. Seff and Mr. Bormel. ... For the Company’s fiscal year ended March 31, 2013, each outside director was entitled to a $10,000 annual fee for annual service as a director. ... Ronald A. Seff, M.D. $10,000 total compensation.
2014-07-29	Dr. Seff has served on the Audit and Compensation Committees of the Company for eight years. The members of the Audit Committee during the fiscal year ended March 31, 2014 were Mr. Bormel (Chairman), Dr. Seff and Mr. Luskin. The Board’s Compensation Committee consists of Mr. Luskin (Chairman), Dr. Seff and Mr. Bormel. The following table summarizes the compensation paid to directors for the fiscal year ended March 31, 2014: Ronald A. Seff, M.D. received $10,000.
2015-07-28	The Audit Committee members during the fiscal year ended March 31, 2015 were Mr. Bormel (Chairman), Dr. Seff and Mr. Luskin. The Compensation Committee consists of Mr. Luskin (Chairman), Dr. Seff and Mr. Bormel. The following table summarizes the compensation paid to directors for the fiscal year ended March 31, 2015: Ronald A. Seff, M.D. $10,000 total.
2016-07-25	The members of the Audit Committee during the fiscal year ended March 31, 2016 were Mr. Bormel (Chairman), Dr. Seff and Mr. Luskin. None of the Audit Committee members is an employee of the Company and each is independent under existing NYSE MKT and SEC requirements. The Board’s Compensation Committee consists of Mr. Luskin (Chairman), Dr. Seff and Mr. Bormel, none of whom is an employee of the Company and each of whom is independent under existing NYSE MKT and SEC requirements. During the Company’s fiscal year ended March 31, 2016, each outside director was entitled to a $10,000 annual fee for annual service as a director. The following table summarizes the compensation paid to directors for the fiscal year ended March 31, 2016: Ronald A. Seff, M.D. $10,000 total.
2017-07-26	Dr. Seff serves on the Audit and Compensation Committees of the Company and has a broad understanding of the Company, its management, and its operations. The following table summarizes the compensation paid to directors for the fiscal year ended March 31, 2017: Ronald A. Seff, M.D. $10,000 total compensation.
2018-07-25	Dr. Seff serves on the Audit and Compensation Committees of the Company and has a broad understanding of the Company, its management, and its operations. The members of the Audit Committee during the fiscal year ended March 31, 2018 were Mr. Bormel (Chairman), Dr. Seff and Mr. Luskin. The Board’s Compensation Committee consists of Mr. Luskin (Chairman), Dr. Seff and Mr. Bormel, none of whom is an employee of the Company and each of whom is independent under existing NYSE MKT and SEC requirements. The following table summarizes the compensation paid to directors for the fiscal year ended March 31, 2018: Ronald A. Seff, M.D. $10,000 total.
2019-07-23	The members of the Audit Committee during the fiscal year ended March 31, 2019 were Mr. Bormel (Chairman), Dr. Seff and Mr. Luskin. ... The Board's Compensation Committee consists of Mr. Luskin (Chairman), Dr. Seff and Mr. Bormel... During the Company’s fiscal year ended March 31, 2019, each outside director was entitled to a $10,000 annual fee for annual service as a director. ... The following table summarizes the compensation paid to directors for the fiscal year ended March 31, 2019: Ronald A. Seff, M.D. $10,000 total.
2020-07-24	Dr. Seff serves on the Audit and Compensation Committees of the Company. During the Company’s fiscal year ended March 31, 2020, each outside director was entitled to a $10,000 annual fee for annual service as a director. The following table summarizes the compensation paid to directors for the fiscal year ended March 31, 2020: Ronald A. Seff, M.D., Total compensation $10,000.
2021-07-22	The following table summarizes the compensation paid to directors for the fiscal year ended March 31, 2021: Name: Ronald A. Seff, M.D. Fees Earned or Paid in Cash: $10,000 Option Awards: $0 Total: $10,000 Dr. Seff serves on the Audit and Compensation Committees of the Company and has a broad understanding of the Company, its management, and its operations. The members of the Audit Committee during the fiscal year ended March 31, 2021 were Mr. Bormel (Chairman), Dr. Seff and Mr. Luskin. The Board’s Compensation Committee consists of Mr. Luskin (Chairman), Dr. Seff and Mr. Bormel.
2023-07-20	Dr. Seff serves on the Audit and Compensation Committees of the Company. For the Company’s fiscal year ended March 31, 2023, each outside director was entitled to a $10,000 annual fee for annual service as a director. The following table summarizes the compensation paid to directors for the fiscal year ended March 31, 2023: Ronald A. Seff, M.D. $10,000 total.
2024-07-29	Dr. Seff has been in the private practice of ophthalmology since 1977.